Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

On becoming 65 in Ontario. Effects of drug plan eligibility on use of prescription medicines.

Grootendorst PV, O'Brien BJ, Anderson GM.

Med Care. 1997 Apr;35(4):386-98.

PMID:
9107206
2.

Family income and the impact of a children's health insurance program on reported need for health services and unmet health need.

Feinberg E, Swartz K, Zaslavsky A, Gardner J, Walker DK.

Pediatrics. 2002 Feb;109(2):E29.

PMID:
11826239
3.

The influence of prescription drug insurance on psychotropic and non-psychotropic drug utilization in Canada.

Sarma S, Basu K, Gupta A.

Soc Sci Med. 2007 Dec;65(12):2553-65. Epub 2007 Aug 29.

PMID:
17761377
4.

A comparison of alternative models of prescription drug utilization.

Grootendorst PV.

Health Econ. 1995 May-Jun;4(3):183-98.

PMID:
7550769
5.
6.

Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.

Lillard LA, Rogowski J, Kington R.

Med Care. 1999 Sep;37(9):926-36.

PMID:
10493470
7.
8.

How complete are drug history profiles that are based on public drug benefit claims?

Paterson JM, Suleiman A, Hux JE, Bell C.

Can J Clin Pharmacol. 2008 Winter;15(1):e108-16. Epub 2008 Feb 19.

PMID:
18283220
9.

How does complementary private prescription drug insurance coverage affect seniors' use of publicly funded medications?

Allin S, Law MR, Laporte A.

Health Policy. 2013 May;110(2-3):147-55. doi: 10.1016/j.healthpol.2013.02.010. Epub 2013 Mar 19.

PMID:
23522381
10.

Ability to pay and the decision to medicate.

Stuart B, Grana J.

Med Care. 1998 Feb;36(2):202-11.

PMID:
9475474
11.
12.
13.

Drug insurance instability and its correlates: results from the 2000 Medical Expenditure Panel Survey.

Gupta K, Cline RR, Schondelmeyer SW.

Res Social Adm Pharm. 2006 Jun;2(2):232-53.

PMID:
17138510
14.

The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use.

Hansen RA, Schommer JC, Cline RR, Hadsall RS, Schondelmeyer SW, Nyman JA.

Res Social Adm Pharm. 2005 Jun;1(2):139-57.

PMID:
17138472
15.

Prescription drug coverage, health, and medication acquisition among seniors with one or more chronic conditions.

Jackson JE, Doescher MP, Saver BG, Fishman P.

Med Care. 2004 Nov;42(11):1056-65.

PMID:
15586832
16.

Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada.

Hanley GE, Morgan S.

Soc Sci Med. 2009 Mar;68(5):919-24. doi: 10.1016/j.socscimed.2008.12.008. Epub 2009 Jan 8.

PMID:
19135288
17.

Inequity in publicly funded physician care: what is the role of private prescription drug insurance?

Allin S, Hurley J.

Health Econ. 2009 Oct;18(10):1218-32. doi: 10.1002/hec.1428.

PMID:
19097042
18.

Role of health insurance coverage in women's access to prescription medicines.

Ranji UR, Wyn R, Salganicoff A, Yu H.

Womens Health Issues. 2007 Nov-Dec;17(6):360-6.

PMID:
18042485
19.

The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities.

Li X, Guh D, Lacaille D, Esdaile J, Anis AH.

Health Policy. 2007 Aug;82(3):340-7. Epub 2006 Nov 28.

PMID:
17134787
20.

Medicare program; Medicare prescription drug benefit. Final rule.

Centers for Medicare & Medicaid Services (CMS), HHS.

Fed Regist. 2005 Jan 28;70(18):4193-585.

Supplemental Content

Support Center